NCT06161246View on ClinicalTrials.gov

A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions

Injection Site Discomfort

Interventions

DEVICE

Vibrating Beauty Bar

A vibrating beauty bar will be used at the injection site for patient comfort.

Trial Locations (1)

60611

DeNova Research, Chicago

Sponsors

Lead Sponsor

Collaborators (1)

DeNova Research

All Listed Sponsors

collaborator

DeNova Research

OTHER

lead

Galderma R&D

INDUSTRY

NCT06161246 - A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction | Biotech Hunter | Biotech Hunter